Literature DB >> 23008446

Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

Marcin F Osuchowski1, Florin Craciun, Katrin M Weixelbaumer, Elizabeth R Duffy, Daniel G Remick.   

Abstract

The paradigm of systemic inflammatory response syndrome-to-compensatory anti-inflammatory response syndrome transition implies that hyperinflammation triggers acute sepsis mortality, whereas hypoinflammation (release of anti-inflammatory cytokines) in late sepsis induces chronic deaths. However, the exact humoral inflammatory mechanisms attributable to sepsis outcomes remain elusive. In the first part of this study, we characterized the systemic dynamics of the chronic inflammation in dying (DIE) and surviving (SUR) mice suffering from cecal ligation and puncture sepsis (days 6-28). In the second part, we combined the current chronic and previous acute/chronic sepsis data to compare the outcome-dependent inflammatory signatures between these two phases. A composite cytokine score (CCS) was calculated to compare global inflammatory responses. Mice were never sacrificed but were sampled daily (20 μl) for blood. In the first part of the study, parameters from chronic DIE mice were clustered into the 72, 48, and 24 h before death time points and compared with SUR of the same post-cecal ligation and puncture day. Cytokine increases were mixed and never preceded chronic deaths earlier than 48 h (3- to 180-fold increase). CCS demonstrated simultaneous and similar upregulation of proinflammatory and anti-inflammatory compartments at 24 h before chronic death (DIE 80- and 50-fold higher versus SUR). In the second part of the study, cytokine ratios across sepsis phases/outcomes indicated steady proinflammatory versus anti-inflammatory balance. CCS showed the inflammatory response in chronic DIE was 5-fold lower than acute DIE mice, but identical to acute SUR. The systemic mixed anti-inflammatory response syndrome-like pattern (concurrent release of proinflammatory and anti-inflammatory cytokines) occurs irrespective of the sepsis phase, response magnitude, and/or outcome. Although different in magnitude, neither acute nor chronic septic mortality is associated with a predominating proinflammatory and/or anti-inflammatory signature in the blood.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23008446      PMCID: PMC3478412          DOI: 10.4049/jimmunol.1201806

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

1.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection.

Authors:  Jose C Alves-Filho; Fabiane Sônego; Fabricio O Souto; Andressa Freitas; Waldiceu A Verri; Maria Auxiliadora-Martins; Anibal Basile-Filho; Andrew N McKenzie; Damo Xu; Fernando Q Cunha; Foo Y Liew
Journal:  Nat Med       Date:  2010-05-16       Impact factor: 53.440

Review 3.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

4.  Repetitive low-volume blood sampling method as a feasible monitoring tool in a mouse model of sepsis.

Authors:  Katrin M Weixelbaumer; Pierre Raeven; Heinz Redl; Martijn van Griensven; Soheyl Bahrami; Marcin F Osuchowski
Journal:  Shock       Date:  2010-10       Impact factor: 3.454

5.  A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice.

Authors:  Bryan G Belikoff; Stephen Hatfield; Peter Georgiev; Akio Ohta; Dmitriy Lukashev; Jon A Buras; Daniel G Remick; Michail Sitkovsky
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

6.  Chronic sepsis mortality characterized by an individualized inflammatory response.

Authors:  Marcin F Osuchowski; Kathy Welch; Huan Yang; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  Infections of respiratory or abdominal origin in ICU patients: what are the differences?

Authors:  Elena Volakli; Claudia Spies; Argyris Michalopoulos; A B Johan Groeneveld; Yasser Sakr; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-03-15       Impact factor: 9.097

8.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

9.  Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury.

Authors:  Soheyl Bahrami; Linda Pelinka; Anna Khadem; Sonja Maitzen; Gerhard Hawa; Martijn van Griensven; Heinz Redl
Journal:  Crit Care Med       Date:  2010-01       Impact factor: 7.598

10.  Experimentally approaching the ICU: monitoring outcome-based responses in the two-hit mouse model of posttraumatic sepsis.

Authors:  Susanne Drechsler; Katrin M Weixelbaumer; Heinz Redl; Martijn van Griensven; Soheyl Bahrami; Marcin F Osuchowski
Journal:  J Biomed Biotechnol       Date:  2011-01-18
View more
  47 in total

1.  Host derived biomarkers of inflammation, apoptosis, and endothelial activation are associated with clinical outcomes in patients with bacteremia and sepsis regardless of microbial etiology.

Authors:  William O Hahn; Carmen Mikacenic; Brenda L Price; Susanna Harju-Baker; Ronit Katz; Jonathan Himmelfarb; Mark M Wurfel; W Conrad Liles
Journal:  Virulence       Date:  2016-01-28       Impact factor: 5.882

2.  Antagonism of the Neurokinin-1 Receptor Improves Survival in a Mouse Model of Sepsis by Decreasing Inflammation and Increasing Early Cardiovascular Function.

Authors:  Juan R Mella; Evan Chiswick; David Stepien; Rituparna Moitra; Elizabeth R Duffy; Arthur Stucchi; Daniel Remick
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 3.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 4.  The future of murine sepsis and trauma research models.

Authors:  Philip A Efron; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  J Leukoc Biol       Date:  2015-06-01       Impact factor: 4.962

5.  Neurokinin-1 Receptor Deficiency Improves Survival in Murine Polymicrobial Sepsis Through Multiple Mechanisms in Aged Mice.

Authors:  Juan R Mella; Arthur F Stucchi; Elizabeth R Duffy; Daniel G Remick
Journal:  Shock       Date:  2019-07       Impact factor: 3.454

6.  Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis.

Authors:  Fabricia Petronilho; Drielly Florentino; Lucinéia Gainski Danielski; Luiz Carlos Vieira; Maryane Modolon Martins; Andriele Vieira; Sandra Bonfante; Mariana Pereira Goldim; Francieli Vuolo
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

7.  Inhibition of IκB Kinase Attenuates the Organ Injury and Dysfunction Associated with Hemorrhagic Shock.

Authors:  Regina Sordi; Fausto Chiazza; Florence L Johnson; Nimesh S A Patel; Karim Brohi; Massimo Collino; Christoph Thiemermann
Journal:  Mol Med       Date:  2015-06-18       Impact factor: 6.354

8.  Caffeine Improves Heart Rate Without Improving Sepsis Survival.

Authors:  Gustavo Bauzá; Daniel Remick
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

Review 9.  Epigenetic coordination of acute systemic inflammation: potential therapeutic targets.

Authors:  Vidula Vachharajani; Tiefu Liu; Charles E McCall
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

10.  Identification of a Novel Antisepsis Pathway: Sectm1a Enhances Macrophage Phagocytosis of Bacteria through Activating GITR.

Authors:  Xingjiang Mu; Peng Wang; Xiaohong Wang; Yutian Li; Hongyan Zhao; Qianqian Li; Kobina Essandoh; Shan Deng; Tianqing Peng; Guo-Chang Fan
Journal:  J Immunol       Date:  2020-08-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.